| Pharmaceutical pricing in the developing world: issues of access to medicines. | |
| | |
MedLine Citation:
|
PMID: 19807429 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Events during 2001 raised greater awareness in the global community to the problems facing less developed countries in gaining access to essential medicines because they are not affordable. The difference between the price of medicines and income in many developing countries is significant and consequently, price stands as an important barrier to access. Steps taken this year to clarify the flexibility clauses of the Trade-Related Aspects of Intellectual Property Rights Agreement - international discussions on the feasibility of applying a differential pricing mechanism and the Global Fund to Fight AIDS, Tuberculosis and Malaria - have been important advances in the process that seeks to ensure access to affordably priced medicines. This paper reviews recent developments and proposals concerning issues of drug pricing in developing countries and discusses what still needs to be done in order to improve access. |
| | |
Authors:
|
Monique F Mrazek |
Related Documents
:
|
19169459 - Recent development and improvement for boron hydride-based catalytic asymmetric reducti... 9339859 - Addiction medicine: a place for faculty development. 7246509 - Forensic medicine in britain. 20416549 - Fractals for physicians. 1457069 - Hydrophilic expanders for the congenital anophthalmic socket. 11183389 - Bp: developing excellence in the global enterprise. 11953349 - Management of uninvestigated dyspepsia: review and commentary. 1460239 - Use of unsharp masks with high-contrast retinal nerve fibre layer photographs. 15187839 - Treatment of the mangled lower extremity after a terrorist blast injury. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert review of pharmacoeconomics & outcomes research Volume: 2 ISSN: 1744-8379 ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Publication Date: 2002 Feb |
Date Detail:
|
Created Date: 2009-10-07 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101132257 Medline TA: Expert Rev Pharmacoecon Outcomes Res Country: England |
Other Details:
|
Languages: eng Pagination: 43-50 Citation Subset: - |
Affiliation:
|
European Observatory on Healthcare Systems and LSE Health and Social Care, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK. M.F.Mrazek@lse.ac.uk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Efficiency-based pharmacotherapy: a new approach for decision-making in medical practice.
Next Document: Toward new legislation on drugs in Europe.